https://www.selleckchem.com/pr....oducts/gsk3368715.ht
Elevated lipoprotein(a) is a quantitative genetic trait whose value in risk prediction over-rides genetic testing; treatment relies on RNA therapeutics. SUMMARY Genetic testing is not at present commonly available for managing dyslipidaemias. Rapidly advancing technology may presage wider use, but its worth will require demonstration of cost-effectiveness and a healthcare workforce trained in genomic medicine.PURPOSE OF REVIEW Atrial arrhythmias commonly occur in patients with advanced heart failure with reduced ejection fraction (HF
Like
Comment
Share
